A Clinical Study of SHR-2004 Injection in Preventing Venous Thromboembolism in Patients Undergoing Total Knee Arthroplasty
A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 1165 participants.
Also called NCT06825416
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose prevention
- Phase
- Phase 3
- Enrolled
- 1,165 participants
- Registry
-
NCT06825416
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- China
- Registry status
- Completed
Technical summary
Registry record NCT06825416. Randomized; quadruple masking; primary purpose prevention. Start 2025-03-16 (actual); primary completion 2026-02-15 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- A Clinical Study of SHR-2004 Injection in Preventing Venous Thromboembolism in Patients Undergoing Total Knee Arthroplasty
- Condition
- Prevention of Arterial and Venous Thrombosis
- Intervention (Drug)
- SHR-2004 injection
- Intervention (Drug)
- SHR-2004 injection
- Intervention (Drug)
- Enoxaparin sodium injection
- Intervention (Drug)
- Enoxaparin sodium injection placebo
- Intervention (Drug)
- SHR-2004 placebo
- Intervention (Drug)
- SHR-2004 placebo
- Lead sponsor
- Beijing Suncadia Pharmaceuticals Co., Ltd
Record details
- Record id
cardio:ct-nct06825416- Content hash
13d0c3c91eaf83cd9260839ff5818c23a280791eb27a64ccd23fc705b136ee64